For help on how to get the results you want, see our search tips.
109 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Categories
Human Remove Human filter
-
List item
Referral: Flurbiprofen Geiser
flurbiprofen, associated names: Flurbiprofen Sejmet, Mentocaína Spray, Flurbiprofeno Geiser, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/10/2019, EC decision date: 16/12/2019, Last updated: 20/01/2020 -
List item
Referral: Syner-Kinase and associated names
urokinase, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/02/2019, EC decision date: 16/05/2019, Last updated: 03/06/2019 -
List item
Referral: Diotop capsules
diclofenac/omeprazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/11/2018, EC decision date: 31/01/2019, Last updated: 15/02/2019 -
List item
Referral: Diclofenac Sodium Spray Gel 4%
diclofenac sodium, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/11/2018, EC decision date: 18/01/2019, Last updated: 14/02/2019 -
List item
Referral: Perlinring and associated names
etonogestrel, ethinylestradiol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/10/2018, EC decision date: 18/12/2018, Last updated: 21/01/2019 -
List item
Referral: Paclitaxel Hetero and associated names
paclitaxel, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/10/2018, EC decision date: 11/01/2019, Last updated: 21/01/2019 -
List item
Referral: Alcover and associated names
sodium oxybate, associated names: n/a, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/01/2017, EC decision date: 18/12/2017, Last updated: 12/01/2018 -
List item
Referral: Paracetamol/Ibuprofen 500 mg/150 mg film-coated tablets
paracetamol-ibuprofen, associated names: Paracomb, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/05/2017, EC decision date: 07/08/2017, -
List item
Referral: Diclofenac epolamine 50 mg tablets
diclofenac, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 22/09/2016, -
List item
Referral: Tobramycin VVB and associated names
tobramycin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/01/2015, EC decision date: 04/04/2016, -
List item
Referral: Myoson and associated names
tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, -
List item
Referral: Seasonique and associated names
levonorgestrel / ethinylestradiol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 12/01/2015, -
List item
Referral: Dexamed and associated names
Dexamfetamine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, -
List item
Referral: Nanotop and associated names
human albumin, denatured, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 28/02/2014, -
List item
Referral: Tibolona Aristo and Tibocina and associated names
Tibolone, associated names: Tibolon Aristo, Tibolinia, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 05/03/2014, -
List item
Referral: Valebo and associated names
alendronic acid and alfacalcidol, associated names: Tevabone, Teboneva, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 10/03/2014, -
List item
Referral: Okrido
prednisolone sodium phosphate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 05/09/2013, -
List item
Referral: Didanosine
didanosine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/09/2013, EC decision date: 20/11/2013, -
List item
Referral: Methylphenidate Sandoz
methylphenidate hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2013, EC decision date: 09/10/2013, -
List item
Referral: Methylphenidate Hexal
methylphenidate hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2013, EC decision date: 09/10/2013, -
List item
Referral: Ciclosporin IDL
ciclosporin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 22/07/2010, -
List item
Referral: Avalox
moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, -
List item
Referral: Furosemide Vitabalans
furosemide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/02/2013, EC decision date: 14/05/2013, -
List item
Referral: Simvastatin Vale
simvastatin, associated names: Simvastatin Vale pharmaceuticals, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/03/2013, EC decision date: 27/05/2013, -
List item
Referral: Loraxin
loratadine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/10/2012, EC decision date: 20/12/2012,